Emma Tallantyre

Clinical Outcomes of Escalation vs Early Intensive Disease-Modifying Therapy in Patients With Multiple Sclerosis

Katharine Harding, Owain Williams, Mark Willis et al. · JAMA Neurology · 2019 · 342 citations · Full text

Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions

Emma Tallantyre, Jennifer Dixon, Ian Donaldson et al. · Neurology · 2011 · 214 citations · Full text

Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial

Rustam Al‐Shahi Salman, M. J. S. Dennis, PAG Sandercock et al. · The Lancet · 2019 · 188 citations · Full text

Clinico-pathological evidence that axonal loss underlies disability in progressive multiple sclerosis

Emma Tallantyre, Lars Bø, Omar Alrawashdeh et al. · Multiple Sclerosis Journal · 2010 · 173 citations

Neurorehabilitation, Neurodegenerative Diseases, Amyotrophic Lateral Sclerosis +13

A Comparison of 3T and 7T in the Detection of Small Parenchymal Veins Within MS Lesions

Emma Tallantyre, Paul S. Morgan, Jennifer Dixon et al. · Investigative Radiology · 2009 · 160 citations